We are grateful for and very satisfied with the support provided by Rephine throughout the entire quality system design project and validation activities.
Client Testimonial
About this Case Study
Launching a new cannabis manufacturing operation is an exciting milestone for any young company. It is also a complex regulatory journey, particularly when GMP systems, facilities and validation activities need to be built from the ground up.
For this newly founded organisation, limited internal GMP experience meant external support was essential to design a compliant manufacturing plant, implement a workable Quality Management System and prepare for EU GMP inspection.
Â
Rephine partnered closely with the client from the earliest stages of facility design through to qualification, validation and staff training. The focus was on creating a QMS that was practical, understandable and fit for a growing cannabis manufacturing environment, while embedding GMP expectations into daily operations.
Â
By combining technical expertise with a supportive and hands on approach, Rephine helped the client move confidently from start up to EU GMP authorised manufacturer.
Â
Key outcomes included:
- Authorisation to manufacture cannabis validation batches under EU GMP
- A fit for purpose QMS aligned with both GMP and GACP activities
- Operational readiness of a new GMP manufacturing plant and QC laboratory
- Improved regulatory confidence through training and internal audits
- GMP principles embedded across teams from the outset
Download the full case study to learn
- How new manufacturers can build GMP compliance step by step
- Why early GMP involvement is critical for facility design and validation
- How practical consultancy supports sustainable compliance from day one
Result
A GMP compliant cannabis manufacturing operation with strong foundations for future growth.
Download the Case Study
View our other resources and company news
A mid-sized pharmaceutical company embarked on a three-year digital transformation to validate TrackWise Digital across three sequential phases. See how full operational support within ValGenesis...
As regulatory demands grow, even strong QA teams reach their limits. Here is how flexible QA support helps pharmaceutical companies manage change, reduce risk and...
Rephine Barcelona S.L. is now accredited to ISO/IEC 17020 as an inspection body for specific GMP and GDP audit activities. We explain what the accreditation...
Relying on historical cleaning limits or visual cleanliness checks to justify shared manufacturing carries more regulatory risk than many sites realise. Find out what a...
Every change to a validated system carries risk. Discover the core components, roles and best practices that keep Change Management in CSV projects controlled, compliant...
A global cosmetics manufacturer wanted to enter the OTC pharmaceutical market but had zero GMP experience. In 12 months, their Spanish production site achieved full...
Turn data integrity findings into a sustainable, risk based remediation plan. A practical 7 phase framework for pharma labs....
Transport validation is a regulatory requirement under EU GMP Annex 15, yet many pharmaceutical companies still struggle with route selection and risk assessment. This guide...
Watch our webinar with Rephine and ValGenesis on modern, inspection-ready validation: what EU GMP Annex 11 and ALCOA+ now expect, and where AI fits in...